Functional characterization of novel germline TP53 variants in Swedish families-Reference-Cited by-同舟云学术

Functional characterization of novel germline TP53 variants in Swedish families

Published:2019-07-02 Issue:3 Volume:96 Page:216-225
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:Clin Genet

Author:

Kharaziha Pedram¹^ORCID,Ceder Sophia¹,Axell Olga¹,Krall Moritz¹,Fotouhi Omid¹,Böhm Stefanie¹,Lain Sonia²,Borg Åke³,Larsson Catharina¹,Wiman Klas G.¹,Tham Emma⁴⁵,Bajalica‐Lagercrantz Svetlana¹⁵

Affiliation:

1. Department of Oncology‐Pathology, Karolinska Institute, Cancer Center KarolinskaKarolinska University Hospital Stockholm Sweden

2. Department of Microbiology Tumor and Cell BiologyKarolinska Institute Stockholm Sweden

3. Division of Oncology‐PathologyLund University Lund Sweden

4. Department of Molecular Medicine and SurgeryKarolinska Institute Stockholm Sweden

5. Department of Clinical GeneticsKarolinska University Hospital Stockholm Sweden

Funder

Radiumhemmets Forskningsfonder

Stiftelsen Längmanska Kulturfonden

Cancerfonden

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cge.13564

Reference28 articles.

1. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study

2. Síndrome de Li-Fraumeni

3. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study

4. Li-Fraumeni syndrome: cancer risk assessment and clinical management

5. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li–Fraumeni syndrome;Scientific Reports;2024-07-26

2. EGFR-mutated lung cancer as a secondary neoplasm in a patient with Li-Fraumeni syndrome: case report;AME Case Reports;2024-07

3. Functional assay for assessment of pathogenicity of BAP1 variants;Human Molecular Genetics;2023-11-13

4. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer;BMC Cancer;2023-08-10

5. Emerging insights into ethnic-specific TP53 germline variants;JNCI: Journal of the National Cancer Institute;2023-06-23